Bio + Health

Consumers as a New Class of Payor

Julie Yoo Posted August 27, 2024

The portion of healthcare spend covered directly by consumers has shot up in the last several years—as of 2022, total out-of-pocket healthcare expenditures reached $471 billion. As such, consumers are effectively a new class of payor. And a number of opportunities exist to build solutions for those consumers (aka these new “micro payors”) to fund, navigate, and manage their healthcare purchases.

.

What do we mean by “payor”

Let’s first define the scope of what we mean by “consumers as payors”—we’re referring to any use case in which a consumer is shopping a) with a known financial budget, b) against a universe of transparently priced goods and services.

This definition accommodates the scenarios in which the funding of the shopping budget is from a third party versus out-of-pocket, but where the responsibility for use of the budget is in the hands of the consumer—for instance, a consumer may be granted a budget by their employer to shop for a certain type of healthcare product or service, like in the case of ICHRA (e.g. Thatch provides employees with a pre-loaded card to shop for health insurance) or fertility benefits programs (e.g. Carrot provides eligible employees with a pre-loaded card to shop across a network of fertility clinics).

Even when a consumer is covered by a traditional health plan, the surface area of the deductible and non-covered services exposes enough of a gap in consumer-friendly services to warrant purpose-built solutions to improve and facilitate these “consumer as a micro payor” experiences.

Company building opportunities

Here are a few areas we view as compelling company building opportunities to serve consumers as a new class of payor:

Health insurance

Medicare Advantage and ACA marketplaces are current examples of consumers shopping and paying for health insurance directly, where funding comes from a combination of out-of-pocket payments and government subsidies. The aforementioned ICHRA concept is another example of an employer-sponsored, “defined contribution” product, in which the employer creates a budget for each employee to shop for their own health insurance on ACA marketplaces, instead of limiting their choice to 1 or 2 pre-selected plans.

Shopping for health insurance in a way that is intuitive, compliant, and tax benefit-friendly is a non-trivial feat, so we see opportunities to build novel infrastructure to seamlessly integrate together a mess of legacy payments and enrollment systems (e.g. government, private insurance, marketplace, TPAs, payroll), provide audit trails and policy frameworks to comply with insurance and tax laws, and even to create a new semantic/conversational layer to make the health insurance shopping experience understandable to the average consumer. Ideally these platforms also incorporate or integrate with the network of products and services that consumers will utilize under their insurance benefits, or even create marketplaces for consumers to be made aware of relevant offerings.

Ancillary financing products

We also see opportunity to provide financing products to consumers, whether it be to fund below-the-deductible purchases by members of high-deductible health plans, or to create health plan alternatives for the uninsured or underinsured. For example, some companies are building payments programs atop tax-advantaged HSA/FSA/HRA infrastructure to manage out-of-pocket medical expenses that are not covered by insurance. Others are developing membership-based programs that direct out-of-pocket spend towards pre-negotiated cash pay services, or implementing ancillary services spending programs (e.g. for groceries, over-the-counter medicines, fertility, etc) through directed spend cards. Healthcare-specific buy-now-pay-later (BNPL) products can be a wedge into a broader spend management solution for patients to manage their medical expenses.

Cash pay-optimized services

Consumers in control of their healthcare budgets will want access to more affordable and consumer-friendly services options than what they could get through legacy health plan networks. We’re excited about the rising tide of cash-pay services that either wrap improved experiences around traditional healthcare services (e.g. AI-powered preventative care clinics delivering novel bundles of lab tests), or simply aggregate demand to negotiate better rates and SLAs with healthcare providers (e.g. pre-pay surgical procedures marketplaces). These cash-pay services could be made available through healthcare marketplaces for a more friendly shopping experience, as well.

Disintermediating the bloat

As insurance-covered healthcare costs continue to balloon to unsustainable levels, we see consumer-driven purchasing becoming a more widely utilized release valve that holds the promise of creating more free market dynamics and commensurate price competition in healthcare. While consumer-directed spend is still a relatively small portion of overall healthcare spend, the trendline indicates that this phenomenon of consumers behaving like a new class of payor could potentially become one of the major drivers of how the dollars flow through our healthcare system.

Special thanks to Daisy Wolf for her help on this piece.

About the Contributor
Want More a16z Bio + Health?

Insights, analysis, and additional reading on bio and health, and how both are shaping our future.

Learn More
Recommended For You

Want More Bio+Health?

Insights, analysis, and additional reading on bio and health, and how both are shaping our future.

Sign Up On Substack

Views expressed in “posts” (including podcasts, videos, and social media) are those of the individual a16z personnel quoted therein and are not the views of a16z Capital Management, L.L.C. (“a16z”) or its respective affiliates. a16z Capital Management is an investment adviser registered with the Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. The posts are not directed to any investors or potential investors, and do not constitute an offer to sell — or a solicitation of an offer to buy — any securities, and may not be used or relied upon in evaluating the merits of any investment.

The contents in here — and available on any associated distribution platforms and any public a16z online social media accounts, platforms, and sites (collectively, “content distribution outlets”) — should not be construed as or relied upon in any manner as investment, legal, tax, or other advice. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. Any projections, estimates, forecasts, targets, prospects and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any charts provided here or on a16z content distribution outlets are for informational purposes only, and should not be relied upon when making any investment decision. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, posts may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. All content speaks only as of the date indicated.

Under no circumstances should any posts or other information provided on this website — or on associated content distribution outlets — be construed as an offer soliciting the purchase or sale of any security or interest in any pooled investment vehicle sponsored, discussed, or mentioned by a16z personnel. Nor should it be construed as an offer to provide investment advisory services; an offer to invest in an a16z-managed pooled investment vehicle will be made separately and only by means of the confidential offering documents of the specific pooled investment vehicles — which should be read in their entirety, and only to those who, among other requirements, meet certain qualifications under federal securities laws. Such investors, defined as accredited investors and qualified purchasers, are generally deemed capable of evaluating the merits and risks of prospective investments and financial matters.

There can be no assurances that a16z’s investment objectives will be achieved or investment strategies will be successful. Any investment in a vehicle managed by a16z involves a high degree of risk including the risk that the entire amount invested is lost. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by a16z is available here: https://a16z.com/investments/. Past results of a16z’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results. Excluded from this list are investments (and certain publicly traded cryptocurrencies/ digital assets) for which the issuer has not provided permission for a16z to disclose publicly. As for its investments in any cryptocurrency or token project, a16z is acting in its own financial interest, not necessarily in the interests of other token holders. a16z has no special role in any of these projects or power over their management. a16z does not undertake to continue to have any involvement in these projects other than as an investor and token holder, and other token holders should not expect that it will or rely on it to have any particular involvement.

With respect to funds managed by a16z that are registered in Japan, a16z will provide to any member of the Japanese public a copy of such documents as are required to be made publicly available pursuant to Article 63 of the Financial Instruments and Exchange Act of Japan. Please contact compliance@a16z.com to request such documents.

For other site terms of use, please go here. Additional important information about a16z, including our Form ADV Part 2A Brochure, is available at the SEC’s website: http://www.adviserinfo.sec.gov.